Go Unlimited with Magzter GOLD
Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just
Try GOLD - Free
Range of options to cut debt load, says Biocon
Mint Mumbai
|February 10, 2024
Co had borrowed to buy US firm for 3.3 bn; Net debt now at 1.1 billion
Biopharmaceutical firm Biocon Ltd will "remain focused" on reducing its debt taken on to buy the $3.3 billion generics portfolio of American drugmaker Viatris, a top executive said.
On 8 February, the company said it had made a prepayment of $200 million over the preceding quarter, which brought its group-level debt down to $1.1 billion.
Biocon's net debt rose to $1.9 billion in December 2022, as it sought funds to complete the mega-transaction for Viatris.
"The debt levels have been reduced to $1.1 billion at the group level and while the debt levels are comfortable now, we'd like to perhaps get to a level of three times the multiple of Ebitda (earnings before interest, taxes, depreciation, and amortization)," said Peter Bains, group CEO for Biocon Ltd in an interview with Mint.
Biocon's Ebitda for FY23 stood at 2,888 crore-three times that is 18,664 crore ($1.04 billion).
This story is from the February 10, 2024 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
Bank-funded acquisitions won't displace private credit
The Reserve Bank of India's (RBI) draft framework for bank-led acquisition finance marks a decisive policy turn: Indian banks can now enter the acquisition finance market within a clear perimeter, reshaping the competitive dynamics between banks and private credit funds.
3 mins
November 20, 2025
Mint Mumbai
Air India lobbies to use airspace over China's Xinjiang
India-China flights resumed after a five-year hiatus.
1 mins
November 20, 2025
Mint Mumbai
Nitish Kumar to take oath as Bihar CM
JD(U) supremo Nitish Kumar to be sworn-in as Bihar chief minister for a record 10th time.
1 min
November 20, 2025
Mint Mumbai
A fresh perspective on abstraction in art
A new exhibition in Mumbai showcases different approaches to abstraction by artists like Zarina, Seher Shah and Mehlli Gobhai
3 mins
November 20, 2025
Mint Mumbai
Govt eyes post-cut GST revenue surge
FinMin expects Nov GST receipts growth to rebound to 10%
2 mins
November 20, 2025
Mint Mumbai
PayMate pulls plug on West Asia operations
The Visa-backed B2B payments firm is scrambling to raise more funds
2 mins
November 20, 2025
Mint Mumbai
Exide's dual bet: Can lithium-ion offset a weakening core?
Exide Industries Ltd is struggling to fuel its core lead-acid business while simultaneously turning its capex-heavy lithium-ion venture into a viable second growth engine.
1 mins
November 20, 2025
Mint Mumbai
Bank-funded acquisitions won’t displace private credit
The Reserve Bank of India's (RBI) draft framework for bank-led acquisition finance marks a decisive policy turn: Indian banks can now enter the acquisition finance market within a clear perimeter, reshaping the competitive dynamics between banks and private credit funds.
3 mins
November 20, 2025
Mint Mumbai
Afghanistan trade minister seeks India investments, goods
Afghanistan's Taliban trade minister arrived in India on Wednesday on a maiden visit to draw greater investments and goods as both countries consider ways to enhance their relations in the backdrop of souring relations with neighboring Pakistan.
1 min
November 20, 2025
Mint Mumbai
Fractal Analytics bets heavily on R&D in AI race before IPO
Enterprise artificial intelligence firm Fractal Analytics plans to maintain high research and development (R&D) spending ahead of its market debut for which a date has not yet been set, a top executive has said.
2 mins
November 20, 2025
Listen
Translate
Change font size